Adoption of evidence-informed guidelines in prescribing protease inhibitors for HIV-Tuberculosis co-infected patients on rifampicin and effects on HIV treatment outcomes in Uganda

Adoption of evidence-informed guidelines in prescribing protease inhibitors for HIV-Tuberculosis co-infected patients on rifampicin and effects on HIV treatment outcomes in Uganda

Abstract Background We aimed to determine how emerging evidence over the past decade informed how Ugandan HIV clinicians prescribed protease inhibitors (PIs) in HIV patients on rifampicin-based tuberculosis (TB) treatment and how this affected HIV treatment outcomes. Methods We reviewed clinical rec...

Full description

Bibliographic Details
Main Authors: Frank Mulindwa, Barbara Castelnuovo, Bruce Kirenga, Dennis Kalibbala, Priscilla Haguma, Martin Muddu, Fred C. Semitala
Format: Article
Language:English
Published: BMC 2021-08-01
Series:BMC Infectious Diseases
Subjects:
Protease inhibitors
Tuberculosis
Drug-drug interactions
Online Access:https://doi.org/10.1186/s12879-021-06533-6

Similar Items

Similar Items